Lorimer IA - Search Results

1

Inhibition of glioblastoma malignancy by Lgl1.

Gont A, Hanson JE, Lavictoire SJ, Daneshmand M, Nicholas G, Woulfe J, Kassam A, Da Silva VF, Lorimer IA. Gont A, et al. Among authors: lorimer ia. Oncotarget. 2014 Nov 30;5(22):11541-51. doi: 10.18632/oncotarget.2580. Oncotarget. 2014. PMID: 25426552 Free PMC article.

2

Targeting retrovirus to cancer cells expressing a mutant EGF receptor by insertion of a single chain antibody variable domain in the envelope glycoprotein receptor binding lobe.

Lorimer IA, Lavictoire SJ. Lorimer IA, et al. J Immunol Methods. 2000 Apr 3;237(1-2):147-57. doi: 10.1016/s0022-1759(99)00219-7. J Immunol Methods. 2000. PMID: 10725459

3

Activation of extracellular-regulated kinases by normal and mutant EGF receptors.

Lorimer IA, Lavictoire SJ. Lorimer IA, et al. Biochim Biophys Acta. 2001 Feb 5;1538(1):1-9. doi: 10.1016/s0167-4889(00)00129-4. Biochim Biophys Acta. 2001. PMID: 11341977 Free article.

4

Antibody recognition of a conformational epitope in a peptide antigen: Fv-peptide complex of an antibody fragment specific for the mutant EGF receptor, EGFRvIII.

Landry RC, Klimowicz AC, Lavictoire SJ, Borisova S, Kottachchi DT, Lorimer IA, Evans SV. Landry RC, et al. Among authors: lorimer ia. J Mol Biol. 2001 May 18;308(5):883-93. doi: 10.1006/jmbi.2001.4628. J Mol Biol. 2001. PMID: 11352579

5

Induction of apoptosis in glioblastoma cells by an atypical protein kinase C pseudosubstrate peptide.

Lorimer IA, Parolin DA, Lavictoire SJ. Lorimer IA, et al. Anticancer Res. 2002 Mar-Apr;22(2A):623-31. Anticancer Res. 2002. PMID: 12014630

6

Interaction of Hsp90 with the nascent form of the mutant epidermal growth factor receptor EGFRvIII.

Lavictoire SJ, Parolin DA, Klimowicz AC, Kelly JF, Lorimer IA. Lavictoire SJ, et al. Among authors: lorimer ia. J Biol Chem. 2003 Feb 14;278(7):5292-9. doi: 10.1074/jbc.M209494200. Epub 2002 Dec 5. J Biol Chem. 2003. PMID: 12471035 Free article.

7

A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients.

Daneshmand M, Parolin DA, Hirte HW, Major P, Goss G, Stewart D, Batist G, Miller WH Jr, Matthews S, Seymour L, Lorimer IA. Daneshmand M, et al. Among authors: lorimer ia. Clin Cancer Res. 2003 Jul;9(7):2457-64. Clin Cancer Res. 2003. PMID: 12855618 Clinical Trial.

8

Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.

Mantha AJ, Hanson JE, Goss G, Lagarde AE, Lorimer IA, Dimitroulakos J. Mantha AJ, et al. Among authors: lorimer ia. Clin Cancer Res. 2005 Mar 15;11(6):2398-407. doi: 10.1158/1078-0432.CCR-04-1951. Clin Cancer Res. 2005. PMID: 15788691

9

Erlotinib in lung cancer - molecular and clinical predictors of outcome.

Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA. Tsao MS, et al. N Engl J Med. 2005 Jul 14;353(2):133-44. doi: 10.1056/NEJMoa050736. N Engl J Med. 2005. PMID: 16014883 Free article. Clinical Trial.

10

Regulation of glioblastoma cell invasion by PKC iota and RhoB.

Baldwin RM, Parolin DA, Lorimer IA. Baldwin RM, et al. Among authors: lorimer ia. Oncogene. 2008 Jun 5;27(25):3587-95. doi: 10.1038/sj.onc.1211027. Epub 2008 Jan 21. Oncogene. 2008. PMID: 18212741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters